Showing results 4 to 4 of 4
< previous
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
Pembrolizumab (MK-3475) vs Standard of Care Chemotherapy in Platinum Pretreated, Recurrent or Metastatic Nasopharyngeal Cancer: the Phase 2 Keynote-122 Study Proceeding/Conference:AHNS 9th International Conference of Head and Neck Cancer | 2016 | 48 |